tradingkey.logo
搜索

Seer Inc

SEER
添加自选
1.690USD
0.0000.00%
收盘 06/26, 16:00美东报价延迟15分钟
93.06M总市值
亏损市盈率 TTM

Seer Inc

1.690
0.0000.00%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

0.00%

5天

-2.87%

1月

-12.44%

6月

-8.15%

今年开始到现在

-7.65%

1年

-20.28%

关键数据
--今开
--最高
--成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
--换手率
--昨收
--最低
--成交额
亏损市盈率静
0.39市净率
0.00%股息率 TTM
-22.76%ROA
2.41052周最高
--量比
-86.60M净利润
55.07M总股本
-1.2461每股收益TTM
1.61Beta
-25.52%ROE
1.65052周最低
--振幅
35.16%毛利率
93.06M总市值
-4.97回报/风险
2.26%风险率

TradingKey Seer Inc股票评分

单位: USD 更新时间: 2026-06-26

操作建议

Seer Inc当前公司基本面数据相对非常健康,增长潜力稳定。当前估值合理,在办公设备行业排名6/7位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价4.00。中期看,股价处于平稳状态。近一个月,市场表现较差,但技术面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Seer Inc评分

相关信息

行业排名
6 / 7
全市场排名
274 / 4566
所属行业
办公设备

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
极度看空

Seer Inc亮点

亮点风险
Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.
业绩增长期
公司处于发展阶段,最新年度总收入16.58M美元
估值合理
公司最新PB估值0.38,处于3年历史合理位
机构减仓
最新机构持股29.42M股,环比减少20.92%
史蒂文·科恩持仓
明星投资者史蒂文·科恩持仓,最新持仓市值13.17K
活跃度降低
近期活跃度降低,过去20天平均换手率-0.45

分析师目标

根据 2 位分析师
买入
评级
4.000
目标均价
+140.96%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Seer Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Seer Inc简介

Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.
公司代码SEER
公司Seer Inc
CEOFarokhzad (Omid C)
网址https://seer.bio/

常见问题

Seer Inc(SEER)的当前股价是多少?

Seer Inc(SEER)的当前股价是 1.66。

Seer Inc的股票代码是什么?

Seer Inc的股票代码是SEER。

Seer Inc股票的52周最高点是多少?

Seer Inc股票的52周最高点是2.41。

Seer Inc股票的52周最低点是多少?

Seer Inc股票的52周最低点是1.65。

Seer Inc的市值是多少?

Seer Inc的市值是91.27M。

现在Seer Inc(SEER)的股票是买入、持有还是卖出?

根据分析师评级,Seer Inc(SEER)的总体评级为买入,目标价格为4.00。

Seer Inc(SEER)股票的每股收益(EPS TTM)是多少

Seer Inc(SEER)股票的每股收益(EPS TTM)是-1.28。
KeyAI